-
1
-
-
7044263390
-
Vaccine adjuvants: Current state and future trends
-
DOI 10.1111/j.0818-9641.2004.01272.x
-
Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol. Cell. Biol. 82(5), 488-496 (2004). (Pubitemid 39421058)
-
(2004)
Immunology and Cell Biology
, vol.82
, Issue.5
, pp. 488-496
-
-
Petrovsky, N.1
Aguilar, J.C.2
-
2
-
-
27144543680
-
Macrophagic myofasciitis in childhood: A controversial entity
-
DOI 10.1016/j.pediatrneurol.2005.05.024, PII S0887899405002699
-
Rivas E, Gomez-Arnaiz M, Ricoy JR et al. Macrophagic myofasciitis in childhood: a controversial entity. Pediatr. Neurol. 33(5), 350-356 (2005). (Pubitemid 41501555)
-
(2005)
Pediatric Neurology
, vol.33
, Issue.5
, pp. 350-356
-
-
Rivas, E.1
Gomez-Arnaiz, M.2
Ricoy, J.R.3
Mateos, F.4
Simon, R.5
Garcia-Penas, J.J.6
Garcia-Silva, M.T.7
Martin, E.8
Vazquez, M.9
Ferreiro, A.10
Cabello, A.11
-
3
-
-
0034841256
-
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
-
Gherardi RK, Coquet M, Cherin P et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 124(Pt 9), 1821-1831 (2001). (Pubitemid 32845443)
-
(2001)
Brain
, vol.124
, Issue.9
, pp. 1821-1831
-
-
Gherardi, R.K.1
Coquet, M.2
Cherin, P.3
Belec, L.4
Moretto, P.5
Dreyfus, P.A.6
Pellissier, J.-F.7
Chariot, P.8
Authier, F.-J.9
-
4
-
-
0343643374
-
Quantitative studies in diphtheria prophylaxis; The primary response
-
pl
-
Holt LB. Quantitative studies in diphtheria prophylaxis; the primary response. Brit. J. Exp. Pathol. 30(4), 289-297, pl (1949).
-
(1949)
Brit. J. Exp. Pathol.
, vol.30
, Issue.4
, pp. 289-297
-
-
Holt, L.B.1
-
5
-
-
0001294999
-
The effect of paraffin oil and mycobacteria on antibody formation and sensitization; A review
-
Freund J. The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review. Am. J. Clin. Pathol. 21(7), 645-656 (1951).
-
(1951)
Am. J. Clin. Pathol.
, vol.21
, Issue.7
, pp. 645-656
-
-
Freund, J.1
-
6
-
-
54249154153
-
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: Results of a Phase I-II randomized clinical trial
-
Keitel WA, Campbell JD, Treanor JJ et al. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a Phase I-II randomized clinical trial. J. Infect. Dis. 198(9), 1309-1316 (2008).
-
(2008)
J. Infect. Dis.
, vol.198
, Issue.9
, pp. 1309-1316
-
-
Keitel, W.A.1
Campbell, J.D.2
Treanor, J.J.3
-
7
-
-
0035145817
-
Antibody response in sheep following immunization with Streptococcus bovis in different adjuvants
-
DOI 10.1023/A:1026757917968
-
Shu Q, Bir SH, Gill HS et al. Antibody response in sheep following immunization with Streptococcus bovis in different adjuvants. Vet. Res. Commun. 25(1), 43-54 (2001). (Pubitemid 32121088)
-
(2001)
Veterinary Research Communications
, vol.25
, Issue.1
, pp. 43-54
-
-
Shu, Q.1
Bird, S.H.2
Gill, H.S.3
Duan, E.4
Xu, Y.5
Hillard, M.A.6
Rowe, J.B.7
-
8
-
-
0017182590
-
Adjuvant effects of diethylaminoethyl-dextran
-
Houston WE, Crabbs CL, Kremer RJ, Springer JW. Adjuvant effects of diethylaminoethyl-dextran. Infect. Immun. 13(6), 1559-1562 (1976).
-
(1976)
Infect. Immun.
, vol.13
, Issue.6
, pp. 1559-1562
-
-
Houston, W.E.1
Crabbs, C.L.2
Kremer, R.J.3
Springer, J.W.4
-
9
-
-
0030457699
-
Adjuvant effect of DEAE-dextran and tetanus toxoid on whole cell heat inactivated phenol preserved typhoid vaccine
-
Kaistha J, Sokhey J, Singh S, Kumar S, John PC, Sharma NC. Adjuvant effect of DEAE-dextran and tetanus toxoid on whole cell heat inactivated phenol preserved typhoid vaccine. Indian J. Pathol. Microbiol. 39(4), 287-292 (1996).
-
(1996)
Indian J. Pathol. Microbiol.
, vol.39
, Issue.4
, pp. 287-292
-
-
Kaistha, J.1
Sokhey, J.2
Singh, S.3
Kumar, S.4
John, P.C.5
Sharma, N.C.6
-
10
-
-
77953264382
-
In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants
-
Bachelder EM, Beaudette TT, Broaders KE et al. In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Mol. Pharm. 7(3), 826-835 (2010).
-
(2010)
Mol. Pharm.
, vol.7
, Issue.3
, pp. 826-835
-
-
Bachelder, E.M.1
Beaudette, T.T.2
Broaders, K.E.3
-
11
-
-
0017744558
-
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation
-
Schorlemmer HU, Bitter-Suermann D, Allison AC. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology 32(6), 929-940 (1977). (Pubitemid 8120584)
-
(1977)
Immunology
, vol.32
, Issue.6
, pp. 929-940
-
-
Schorlemmer, H.U.1
Bitter Suermann, D.2
Allison, A.C.3
-
12
-
-
0038205797
-
Direct binding of toll-like receptor 2 to Zymosan, and Zymosan-induced NF-kB activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A
-
Sato M, Sano H, Iwaki D et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kB activation and TNF-a secretion are down-regulated by lung collectin surfactant protein A. J. Immunol. 171(1), 417-425 (2003). (Pubitemid 36745315)
-
(2003)
Journal of Immunology
, vol.171
, Issue.1
, pp. 417-425
-
-
Sato, M.1
Sano, H.2
Iwaki, D.3
Kudo, K.4
Konishi, M.5
Takahashi, H.6
Takahashi, T.7
Imaizumi, H.8
Asai, Y.9
Kuroki, Y.10
-
13
-
-
32944463876
-
Yeast zymosan a stimulus for TLR2 and dectin-1 induces regulatory antigen-presenting cells and immunological tolerance
-
Dillon S, Agrawal S, Banerjee K et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116(4), 916-928 (2006).
-
(2006)
J. Clin. Invest.
, vol.116
, Issue.4
, pp. 916-928
-
-
Dillon, S.1
Agrawal, S.2
Banerjee, K.3
-
14
-
-
0025084832
-
Nonspecific resistance-enhancing activity of zymosan in experimental bacterial infections
-
Emod J, Joo I. Nonspecific resistance-enhancing activity of zymosan in experimental bacterial infections. Acta. Microbiol. Hung. 37(2), 187-192 (1990). (Pubitemid 20373564)
-
(1990)
Acta Microbiologica Hungarica
, vol.37
, Issue.2
, pp. 187-192
-
-
Emod, J.1
Joo, I.2
-
15
-
-
0021809035
-
Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3-D-glucan and other immunomodulators in murine cells
-
Morikawa K, Takeda R, Yamazaki M, Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear b-1,3-d-glucan and other immunomodulators in murine cells. Cancer Res. 45(4), 1496-1501 (1985). (Pubitemid 15079093)
-
(1985)
Cancer Research
, vol.45
, Issue.4
, pp. 1496-1501
-
-
Morikawa, K.1
Takeda, R.2
Yamazaki, M.3
Mizuno, D.4
-
16
-
-
0018139212
-
Protective effect of glucan in experimentally induced candidiasis
-
Williams DL, Cook JA, Hoffmann EO, Di Luzio NR. Protective effect of glucan in experimentally induced candidiasis. J. Reticuloendothel. Soc. 23(6), 479-490 (1978). (Pubitemid 8394904)
-
(1978)
RES Journal of the Reticuloendothelial Society
, vol.23
, Issue.6
, pp. 479-490
-
-
Williams, D.L.1
Cook, J.A.2
Hoffmann, E.O.3
Di Luzio, N.R.4
-
17
-
-
75449106817
-
Zymosan enhances the mucosal adjuvant activity of poly I:C in a nasal influenza vaccine
-
Ainai A, Ichinohe T, Tamura S et al. Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine. J. Med. Virol. 82(3), 476-484 (2010).
-
(2010)
J. Med. Virol.
, vol.82
, Issue.3
, pp. 476-484
-
-
Ainai, A.1
Ichinohe, T.2
Tamura, S.3
-
18
-
-
0035014397
-
Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system
-
DOI 10.1046/j.1365-2567.2001.01201.x
-
Ara Y, Saito T, Takagi T et al. Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system. Immunology 103(1), 98-105 (2001). (Pubitemid 32453102)
-
(2001)
Immunology
, vol.103
, Issue.1
, pp. 98-105
-
-
Ara, Y.1
Saito, T.2
Takagi, T.3
Hagiwara, E.4
Miyagi, Y.5
Sugiyama, M.6
Kawamoto, S.7
Ishii, N.8
Yoshida, T.9
Hanashi, D.10
Koshino, T.11
Okada, H.12
Okuda, K.13
-
19
-
-
68949092245
-
Fungal zymosan and mannan activate the cryopyrin inflammasome
-
Lamkanfi M, Malireddi RK, Kanneganti TD. Fungal zymosan and mannan activate the cryopyrin inflammasome. J. Biol. Chem. 284(31), 20574-20581 (2009).
-
(2009)
J. Biol. Chem.
, vol.284
, Issue.31
, pp. 20574-20581
-
-
Lamkanfi, M.1
Malireddi, R.K.2
Kanneganti, T.D.3
-
20
-
-
33745242490
-
β-Glucan derived from zymosan acts as an adjuvant for collagen-induced arthritis
-
Hida S, Nagi-Miura N, Adachi Y, Ohno N. b-glucan derived from zymosan acts as an adjuvant for collagen-induced arthritis. Microbiol. Immunol. 50(6), 453-461 (2006). (Pubitemid 43927234)
-
(2006)
Microbiology and Immunology
, vol.50
, Issue.6
, pp. 453-461
-
-
Hida, S.1
Nagi-Miura, N.2
Adachi, Y.3
Ohno, N.4
-
21
-
-
0026781218
-
Stimulation of microbicidal host defence mechanisms against aerosol influenza virus infection by lentinan
-
Irinoda K, Masihi KN, Chihara G, Kaneko Y, Katori T. Stimulation of microbicidal host defence mechanisms against aerosol influenza virus infection by lentinan. Int. J. Immunopharmacol. 14(6), 971-977 (1992).
-
(1992)
Int. J. Immunopharmacol.
, vol.14
, Issue.6
, pp. 971-977
-
-
Irinoda, K.1
Masihi, K.N.2
Chihara, G.3
Kaneko, Y.4
Katori, T.5
-
22
-
-
0023690361
-
Regression induced by lentinan of peritoneal carcinomatoses in a model of colon cancer in rat
-
Jeannin JF, Lagadec P, Pelletier H et al. Regression induced by lentinan, of peritoneal carcinomatoses in a model of colon cancer in rat. Int. J. Immunopharmacol. 10(7), 855-861 (1988).
-
(1988)
Int. J. Immunopharmacol.
, vol.10
, Issue.7
, pp. 855-861
-
-
Jeannin, J.F.1
Lagadec, P.2
Pelletier, H.3
-
23
-
-
0023505484
-
Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: An overview
-
Chihara G, Hamuro J, Maeda YY et al. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview. Cancer Detect. Prev. Suppl. 1, 423-443 (1987).
-
(1987)
Cancer Detect. Prev. Suppl.
, vol.1
, pp. 423-443
-
-
Chihara, G.1
Hamuro, J.2
Maeda, Y.Y.3
-
24
-
-
13844294158
-
Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs
-
DOI 10.1016/j.intimp.2004.12.008
-
Drandarska I, Kussovski V, Nikolaeva S, Markova N. Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs. Int. Immunopharmacol. 5(4), 795-803 (2005). (Pubitemid 40248333)
-
(2005)
International Immunopharmacology
, vol.5
, Issue.4
, pp. 795-803
-
-
Drandarska, I.1
Kussovski, V.2
Nikolaeva, S.3
Markova, N.4
-
25
-
-
42249098141
-
Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism
-
Wang J, Zhou ZD, Xia DJ. Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism. Zhongguo Zhong Xi Yi Jie He Za Zhi 27(1), 60-64 (2007).
-
(2007)
Zhongguo Zhong Xi Yi Jie He Za Zhi
, vol.27
, Issue.1
, pp. 60-64
-
-
Wang, J.1
Zhou, Z.D.2
Xia, D.J.3
-
26
-
-
0024466158
-
Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: A flow cytometric study
-
Abel G, Szollosi J, Chihara G, Fachet J. Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. Int. J. Immunopharmacol. 11(6), 615-621 (1989). (Pubitemid 19239435)
-
(1989)
International Journal of Immunopharmacology
, vol.11
, Issue.6
, pp. 615-621
-
-
Abel, G.1
Szollosi, J.2
Chihara, G.3
Fachet, J.4
-
27
-
-
58149507765
-
Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine
-
Guo Z, Hu Y, Wang D et al. Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine. Vaccine 27(5), 660-665 (2009).
-
(2009)
Vaccine
, vol.27
, Issue.5
, pp. 660-665
-
-
Guo, Z.1
Hu, Y.2
Wang, D.3
-
28
-
-
34247539566
-
Specific immune response to HBsAg is enhanced by -βglucan oligosaccharide containing an α-1→3-linked bond and biased towards M2/Th2
-
Dong SF, Chen JM, Zhang Wet al. Specific immune response to HBsAg is enhanced by -βglucan oligosaccharide containing an a-(1→3)-linked bond and biased towards M2/Th2. Int. Immunopharmacol. 7(6), 725-733 (2007).
-
(2007)
Int. Immunopharmacol.
, vol.7
, Issue.6
, pp. 725-733
-
-
Dong, S.F.1
Chen, J.M.2
Zhang Wet3
-
29
-
-
0017225361
-
In vivo and in vitro macrophage activation by systemic adjuvants
-
Bruley-Rosset M, Florentin I, Mathe G. In vivo and in vitro macrophage activation by systemic adjuvants. Agents Actions 6(1-3), 251-255 (1976).
-
(1976)
Agents Actions
, vol.6
, Issue.1-3
, pp. 251-255
-
-
Bruley-Rosset, M.1
Florentin, I.2
Mathe, G.3
-
30
-
-
77954550824
-
+ T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen
-
10.1155/2010/645213 Epub ahead of print
-
Wang J, Dong S, Liu C et al. -βGlucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen. J. Biomed. Biotechnol. DOI: 10.1155/2010/645213 (2010) (Epub ahead of print).
-
(2010)
J. Biomed. Biotechnol.
-
-
Wang, J.1
Dong, S.2
Liu, C.3
-
32
-
-
65449166078
-
Distinct patterns of dendritic cell cytokine release stimulated by fungal -βglucans and Toll-like receptor agonists
-
Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal -βglucans and Toll-like receptor agonists. Infect. Immun. 77(5), 1774-1781 (2009).
-
(2009)
Infect. Immun.
, vol.77
, Issue.5
, pp. 1774-1781
-
-
Huang, H.1
Ostroff, G.R.2
Lee, C.K.3
Wang, J.P.4
Specht, C.A.5
Levitz, S.M.6
-
33
-
-
79952136886
-
Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded -βglucan particles
-
pii
-
Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded -βglucan particles. MBio 1(3), e00164-e00110, pii (2010).
-
(2010)
MBio
, vol.1
, Issue.3
-
-
Huang, H.1
Ostroff, G.R.2
Lee, C.K.3
Specht, C.A.4
Levitz, S.M.5
-
34
-
-
0022446293
-
Anti-complementary action of polymorphic 'solubility forms' of particulate inulin
-
DOI 10.1016/0161-5890(86)90075-1
-
Cooper PD, Carter M. Anti-complementary action of polymorphic 'solubility forms' of particulate inulin. Mol. Immunol. 23(8), 895-901 (1986). (Pubitemid 16057598)
-
(1986)
Molecular Immunology
, vol.23
, Issue.8
, pp. 895-901
-
-
Cooper, P.D.1
Carter, M.2
-
35
-
-
0024206749
-
The adjuvanticity of g inulin
-
Cooper PD, Steele EJ. The adjuvanticity of g inulin. Immunol. Cell. Biol. 66 ( Pt 5-6), 345-352 (1988).
-
(1988)
Immunol. Cell. Biol.
, vol.66
, Issue.5-6
, pp. 345-352
-
-
Cooper, P.D.1
Steele, E.J.2
-
36
-
-
0022458219
-
The anti-melanoma activity of inulin in mice
-
DOI 10.1016/0161-5890(86)90076-3
-
Cooper PD, Carter M. The anti-melanoma activity of inulin in mice. Mol. Immunol. 23(8), 903-908 (1986). (Pubitemid 16057599)
-
(1986)
Molecular Immunology
, vol.23
, Issue.8
, pp. 903-908
-
-
Cooper, P.D.1
Carter, M.2
-
37
-
-
33846192034
-
Potentiation of photodynamic therapy of cancer by complement: The effect of γ-inulin
-
DOI 10.1038/sj.bjc.6603508, PII 6603508
-
Korbelik M, Cooper PD. Potentiation of photodynamic therapy of cancer by complement: the effect of g-inulin. Br. J. Cancer. 96(1), 67-72 (2007). (Pubitemid 46094641)
-
(2007)
British Journal of Cancer
, vol.96
, Issue.1
, pp. 67-72
-
-
Korbelik, M.1
Cooper, P.D.2
-
38
-
-
0025758163
-
Algammulin a new vaccine adjuvant comprising g inulin particles containing alum: Preparation and in vitro properties
-
Cooper PD, Steele EJ. Algammulin, a new vaccine adjuvant comprising g inulin particles containing alum: preparation and in vitro properties. Vaccine 9(5), 351-357 (1991).
-
(1991)
Vaccine
, vol.9
, Issue.5
, pp. 351-357
-
-
Cooper, P.D.1
Steele, E.J.2
-
39
-
-
0029176545
-
Vaccine adjuvants based on g inulin
-
Cooper PD. Vaccine adjuvants based on g inulin. Pharm. Biotechnol. 6, 559-580 (1995).
-
(1995)
Pharm. Biotechnol.
, vol.6
, pp. 559-580
-
-
Cooper, P.D.1
-
40
-
-
33645218007
-
Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity
-
Petrovsky N. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine 24(Suppl. 2), 26-29 (2006).
-
(2006)
Vaccine
, vol.24
, Issue.2
, pp. 26-29
-
-
Petrovsky, N.1
-
41
-
-
9444239833
-
Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses
-
DOI 10.1111/j.1440-1711.2004.01290.x
-
Silva DG, Cooper PD, Petrovsky N. Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses. Immunol. Cell. Biol. 82(6), 611-616 (2004). (Pubitemid 39563962)
-
(2004)
Immunology and Cell Biology
, vol.82
, Issue.6
, pp. 611-616
-
-
Silva, D.G.1
Cooper, P.D.2
Petrovsky, N.3
-
42
-
-
0026022793
-
Algammulin g inulin/alum hybrid adjuvant has greater adjuvanticity than alum for hepatitis B surface antigen in mice
-
Cooper PD, Turner R, McGovern J. Algammulin (g inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice. Immunol. Lett. 27(2), 131-134 (1991).
-
(1991)
Immunol. Lett.
, vol.27
, Issue.2
, pp. 131-134
-
-
Cooper, P.D.1
Turner, R.2
McGovern, J.3
-
43
-
-
0344950492
-
Use of γ-inulin/liposomes/Vitamin E adjuvant combination in contraceptive vaccines
-
DOI 10.1016/S0378-5173(03)00127-3
-
Fuentes P, Cooper PD, Barnadas R, Sabes M, Osterhoff C, Martinez P. Use of g-inulin/liposomes/Vitamin E adjuvant combination in contraceptive vaccines. Int. J. Pharm. 257(1-2), 85-95 (2003). (Pubitemid 36507035)
-
(2003)
International Journal of Pharmaceutics
, vol.257
, Issue.1-2
, pp. 85-95
-
-
Fuentes, P.1
Cooper, P.D.2
Barnadas, R.3
Sabes, M.4
Osterhoff, C.5
Martinez, P.6
-
44
-
-
79955100977
-
D inulin: A novel immunologically-active stable packing structure comprising -βd-2→1 polyfructo-furanosyl α-d glucose polymers
-
In Press
-
Cooper PD, Petrovsky N. d inulin: a novel, immunologically-active, stable packing structure comprising -βd-[2→1] poly(fructo-furanosyl) α-d glucose polymers. Glycobiology (2010) (In Press).
-
(2010)
Glycobiology
-
-
Cooper, P.D.1
Petrovsky, N.2
-
45
-
-
77952717965
-
An inactivated vero cell-grown Japanese encephalitis vaccine formulated with advax a novel inulin-based adjuvant induces protective neutralizing antibody against homologous and heterologous flaviviruses
-
Lobigs M, Pavy M, Hall RA et al. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. J. Gen. Virol. 91(Pt 6), 1407-1417 (2010).
-
(2010)
J. Gen. Virol.
, vol.91
, Issue.6
, pp. 1407-1417
-
-
Lobigs, M.1
Pavy, M.2
Hall, R.A.3
-
46
-
-
78651250984
-
Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
-
Cristillo AD, Ferrari MG, Hudacik L et al. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. J. Gen. Virol. 92(Pt 1), 128-140 (2011).
-
(2011)
J. Gen. Virol.
, vol.92
, Issue.1
, pp. 128-140
-
-
Cristillo, A.D.1
Ferrari, M.G.2
Hudacik, L.3
-
47
-
-
40549113071
-
Freeing vaccine adjuvants from dangerous immunological dogma
-
DOI 10.1586/14760584.7.1.7
-
Petrovsky N. Freeing vaccine adjuvants from dangerous immunological dogma. Expert Rev. Vaccines 7(1), 7-10 (2008). (Pubitemid 351359053)
-
(2008)
Expert Review of Vaccines
, vol.7
, Issue.1
, pp. 7-10
-
-
Petrovsky, N.1
-
48
-
-
70350490533
-
Humoral pattern recognition molecules: Mannan-binding lectin and ficolins
-
Thiel S, Gadjeva M. Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Adv. Exp. Med. Biol. 653, 58-73 (2009).
-
(2009)
Adv. Exp. Med. Biol.
, vol.653
, pp. 58-73
-
-
Thiel, S.1
Gadjeva, M.2
-
49
-
-
2942731324
-
Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins
-
DOI 10.1093/intimm/dxh084
-
Takahara K, Yashima Y, Omatsu Y et al. Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins. Int. Immunol. 16(6), 819-829 (2004). (Pubitemid 38786523)
-
(2004)
International Immunology
, vol.16
, Issue.6
, pp. 819-829
-
-
Takahara, K.1
Yashima, Y.2
Omatsu, Y.3
Yoshida, H.4
Kimura, Y.5
Kang, Y.-S.6
Steinman, R.M.7
Park, C.G.8
Inaba, K.9
-
50
-
-
33745218281
-
Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells
-
Sheng KC, Pouniotis DS, Wright MD et al. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology 118(3), 372-383 (2006).
-
(2006)
Immunology
, vol.118
, Issue.3
, pp. 372-383
-
-
Sheng, K.C.1
Pouniotis, D.S.2
Wright, M.D.3
-
51
-
-
0032524481
-
Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses
-
DOI 10.1016/S0165-2427(98)00094-4, PII S0165242798000944
-
McKenzie IF, Apostolopoulos V, Lees C et al. Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses. Vet. Immunol. Immunopathol. 63(1-2), 185-190 (1998). (Pubitemid 28288342)
-
(1998)
Veterinary Immunology and Immunopathology
, vol.63
, Issue.1-2
, pp. 185-190
-
-
McKenzie, I.F.C.1
Apostolopoulos, V.2
Lees, C.3
Xing, P.-X.4
Lofthouse, S.5
Osinski, C.6
Popovski, V.7
Acres, B.8
Pietersz, G.9
-
52
-
-
0037081476
-
Oxidised mannan as a novel adjuvant inducing mucosal IgA production
-
DOI 10.1016/S0264-410X(01)00456-X, PII S0264410X0100456X
-
Stambas J, Pietersz G, McKenzie I, Cheers C. Oxidised mannan as a novel adjuvant inducing mucosal IgA production. Vaccine 20(7-8), 1068-1078 (2002). (Pubitemid 34135942)
-
(2002)
Vaccine
, vol.20
, Issue.7-8
, pp. 1068-1078
-
-
Stambas, J.1
Pietersz, G.2
McKenzie, I.3
Cheers, C.4
-
53
-
-
70449339864
-
Altered peptide ligands of myelin basic protein MBP87-99 conjugated to reduced mannan modulate immune responses in mice
-
Katsara M, Yuriev E, Ramsland PA et al. Altered peptide ligands of myelin basic protein (MBP87-99) conjugated to reduced mannan modulate immune responses in mice. Immunology 128(4), 521-533 (2009).
-
(2009)
Immunology
, vol.128
, Issue.4
, pp. 521-533
-
-
Katsara, M.1
Yuriev, E.2
Ramsland, P.A.3
-
54
-
-
54149093133
-
Mannan-Ab28 conjugate prevents Ab-plaque deposition but increases microhemorrhages in the brains of vaccinated Tg2576 APPsw mice
-
Petrushina I, Ghochikyan A, Mkrtichyan M et al. Mannan-Ab28 conjugate prevents Ab-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. J. Neuroinflammation 5, 42 (2008).
-
(2008)
J. Neuroinflammation
, vol.5
, pp. 42
-
-
Petrushina, I.1
Ghochikyan, A.2
Mkrtichyan, M.3
-
55
-
-
0034048871
-
Aloe polymannose enhances anti-coxsackievirus antibody titres in mice
-
DOI 10.1002/1099-1573(200006)14:4<261::AID-PTR579>3.0.CO;2-A
-
Gauntt CJ, Wood HJ, McDaniel HR, McAnalley BH. Aloe polymannose enhances anti-coxsackievirus antibody titres in mice. Phytother. Res. 14(4), 261-266 (2000). (Pubitemid 30410054)
-
(2000)
Phytotherapy Research
, vol.14
, Issue.4
, pp. 261-266
-
-
Gauntt, C.J.1
Wood, H.J.2
McDaniel, H.R.3
McAnalley, B.H.4
-
56
-
-
0033995526
-
Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
-
Kawakami S, Sato A, Nishikawa M, Yamashita F, Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 7(4), 292-299 (2000). (Pubitemid 30119732)
-
(2000)
Gene Therapy
, vol.7
, Issue.4
, pp. 292-299
-
-
Kawakami, S.1
Sato, A.2
Nishikawa, M.3
Yamashita, F.4
Hashida, M.5
-
57
-
-
0030823347
-
HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti- interferon-γ antibody
-
Toda S, Ishii N, Okada E et al. HIV-1- specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-g antibody. Immunology 92(1), 111-117 (1997). (Pubitemid 27380889)
-
(1997)
Immunology
, vol.92
, Issue.1
, pp. 111-117
-
-
Toda, S.1
Ishii, N.2
Okada, E.3
Kusakabe, K.-I.4
Arai, H.5
Hamajima, K.6
Gorai, I.7
Nishioka, K.8
Okuda, K.9
-
58
-
-
34247471316
-
Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes
-
DOI 10.1016/j.biomaterials.2007.03.028, PII S0142961207002670
-
Lu Y, Kawakami S, Yamashita F, Hashida M. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Biomaterials 28(21), 3255-3262 (2007). (Pubitemid 46654220)
-
(2007)
Biomaterials
, vol.28
, Issue.21
, pp. 3255-3262
-
-
Lu, Y.1
Kawakami, S.2
Yamashita, F.3
Hashida, M.4
-
59
-
-
24744448887
-
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against Hepatitis B
-
DOI 10.1016/j.imlet.2005.04.002, PII S0165247805000994
-
Jain S, Singh P, Mishra V, Vyas SP. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett. 101(1), 41-49 (2005). (Pubitemid 41297497)
-
(2005)
Immunology Letters
, vol.101
, Issue.1
, pp. 41-49
-
-
Jain, S.1
Singh, P.2
Mishra, V.3
Vyas, S.P.4
-
60
-
-
25844510763
-
Mannosylated niosomes as carrier adjuvant system for topical immunization
-
DOI 10.1211/jpp.57.9.0012
-
Jain S, Vyas SP. Mannosylated niosomes as carrier adjuvant system for topical immunization. J. Pharm. Pharmacol. 57(9), 1177-1184 (2005). (Pubitemid 41391776)
-
(2005)
Journal of Pharmacy and Pharmacology
, vol.57
, Issue.9
, pp. 1177-1184
-
-
Jain, S.1
Vyas, S.P.2
-
61
-
-
0035010551
-
Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells
-
DOI 10.1016/S1567-5769(01)00052-2, PII S1567576901000522
-
Lee JK, Lee MK, Yun YP et al. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int. Immunopharmacol. 1(7), 1275-1284 (2001). (Pubitemid 32522981)
-
(2001)
International Immunopharmacology
, vol.1
, Issue.7
, pp. 1275-1284
-
-
Lee, J.K.1
Lee, M.K.2
Yun, Y.-P.3
Kim, Y.4
Kim, J.S.5
Kim, Y.S.6
Kim, K.7
Han, S.S.8
Lee, C.-K.9
-
62
-
-
0030834536
-
A comparison of antibody responses to: Veterinary vaccine antigens potentiated by different adjuvants
-
DOI 10.1016/S0264-410X(97)00136-9, PII S0264410X97001369
-
Usinger WR. A comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvants. Vaccine 15(17-18), 1902-1907 (1997). (Pubitemid 27504686)
-
(1997)
Vaccine
, vol.15
, Issue.17-18
, pp. 1902-1907
-
-
Usinger, W.R.1
-
63
-
-
0026717420
-
Antigen dependent adjuvant activity of a polydispersed -β1 4-linked acetylated mannan acemannan
-
Chinnah AD, Baig MA, Tizard IR, Kemp MC. Antigen dependent adjuvant activity of a polydispersed b-(1,4)-linked acetylated mannan (acemannan).Vaccine 10(8), 551-557 (1992).
-
(1992)
Vaccine
, vol.10
, Issue.8
, pp. 551-557
-
-
Chinnah, A.D.1
Baig, M.A.2
Tizard, I.R.3
Kemp, M.C.4
-
64
-
-
67650550954
-
Chitosan-based systems for the delivery of vaccine antigens
-
Arca HC, Gunbeyaz M, Senel S. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev. Vaccines 8(7), 937-953 (2009).
-
(2009)
Expert Rev. Vaccines
, vol.8
, Issue.7
, pp. 937-953
-
-
Arca, H.C.1
Gunbeyaz, M.2
Senel, S.3
-
65
-
-
33745855443
-
Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-α, but not IL-10, production
-
DOI 10.1016/j.cellimm.2006.04.003, PII S0008874906000700
-
Nishiyama A, Tsuji S, Yamashita M, Henriksen RA, Myrvik QN, Shibata Y. Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW264.7 cells results in MAPK activation and TNF-a, but not IL-10, production. Cell. Immunol. 239(2), 103-112 (2006). (Pubitemid 44037541)
-
(2006)
Cellular Immunology
, vol.239
, Issue.2
, pp. 103-112
-
-
Nishiyama, A.1
Tsuji, S.2
Yamashita, M.3
Henriksen, R.A.4
Myrvik, Q.N.5
Shibata, Y.6
-
66
-
-
60049091313
-
Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally
-
Ghendon Y, Markushin S, Vasiliev Y et al. Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally. J. Med. Virol. 81(3), 494-506 (2009).
-
(2009)
J. Med. Virol.
, vol.81
, Issue.3
, pp. 494-506
-
-
Ghendon, Y.1
Markushin, S.2
Vasiliev, Y.3
-
67
-
-
77956386955
-
Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine
-
Chang H, Li X, Teng Y et al. Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine. DNA Cell. Biol. 29(9), 563-568 (2010).
-
(2010)
DNA Cell. Biol.
, vol.29
, Issue.9
, pp. 563-568
-
-
Chang, H.1
Li, X.2
Teng, Y.3
-
68
-
-
77649186195
-
Chitosan-based nanoparticles for improving immunization against hepatitis B infection
-
Prego C, Paolicelli P, Diaz B et al. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine 28(14), 2607-2614 (2010).
-
(2010)
Vaccine
, vol.28
, Issue.14
, pp. 2607-2614
-
-
Prego, C.1
Paolicelli, P.2
Diaz, B.3
-
69
-
-
0030839517
-
N-Trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2)
-
DOI 10.1023/A:1012106907708
-
Kotze AF, Luessen HL, de Leeuw BJ, de Boer BG, Verhoef JC, Junginger HE. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).Pharm. Res. 14(9), 1197-1202 (1997). (Pubitemid 27432543)
-
(1997)
Pharmaceutical Research
, vol.14
, Issue.9
, pp. 1197-1202
-
-
Kotze, A.F.1
Luessen, H.L.2
De Leeuw, B.J.3
De Boer, B.G.4
Verhoef, J.C.5
Junginger, H.E.6
-
70
-
-
0242317689
-
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines
-
DOI 10.1016/S0264-410X(03)00305-0
-
Baudner BC, Giuliani MM, Verhoef JC, Rappuoli R, Junginger HE, Giudice GD. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. Vaccine 21(25-26), 3837-3844 (2003). (Pubitemid 37338211)
-
(2003)
Vaccine
, vol.21
, Issue.25-26
, pp. 3837-3844
-
-
Baudner, B.C.1
Giuliani, M.M.2
Verhoef, J.C.3
Rappuoli, R.4
Junginger, H.E.5
Del Giudice, G.6
-
71
-
-
43249088985
-
Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
-
Borges O, Cordeiro-da-Silva A, Tavares J et al. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. Eur. J. Pharm. Biopharm. 69(2), 405-416 (2008).
-
(2008)
Eur. J. Pharm. Biopharm.
, vol.69
, Issue.2
, pp. 405-416
-
-
Borges, O.1
Cordeiro-Da-Silva, A.2
Tavares, J.3
-
72
-
-
2342621524
-
Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1
-
DOI 10.1016/j.vaccine.2003.11.011, PII S0264410X0300776X
-
Gogev S, de Fays K, Versali MF, Gautier S, Thiry E. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1. Vaccine 22(15-16), 1946-1953 (2004). (Pubitemid 38581064)
-
(2004)
Vaccine
, vol.22
, Issue.15-16
, pp. 1946-1953
-
-
Gogev, S.1
De Fays, K.2
Versali, M.-F.3
Gautier, S.4
Thiry, E.5
-
73
-
-
40849120029
-
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B
-
Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int. J. Pharm. 354(1-2), 235-241 (2008).
-
(2008)
Int. J. Pharm.
, vol.354
, Issue.1-2
, pp. 235-241
-
-
Khatri, K.1
Goyal, A.K.2
Gupta, P.N.3
Mishra, N.4
Vyas, S.P.5
-
74
-
-
70349998153
-
TMC-MCC N-trimethyl chitosan-mono-N-carboxymethyl chitosan nanocomplexes for mucosal delivery of vaccines
-
Sayin B, Somavarapu S, Li XW, Sesardic D, Senel S, Alpar OH. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. Eur. J. Pharm. Sci. 38(4), 362-369 (2009).
-
(2009)
Eur. J. Pharm. Sci.
, vol.38
, Issue.4
, pp. 362-369
-
-
Sayin, B.1
Somavarapu, S.2
Li, X.W.3
Sesardic, D.4
Senel, S.5
Alpar, O.H.6
-
75
-
-
65849217248
-
Cellular immunity induced by H. pylori vaccine with chitosan as adjuvant
-
Gong YF, Xie Y, Zhou NJ et al. Cellular immunity induced by H. pylori vaccine with chitosan as adjuvant. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23(7), 595-599 (2007).
-
(2007)
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
, vol.23
, Issue.7
, pp. 595-599
-
-
Gong, Y.F.1
Xie, Y.2
Zhou, N.J.3
-
76
-
-
0034833470
-
Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice
-
DOI 10.1128/IAI.69.10.6123-6130.2001
-
Shibata Y, Honda I, Justice JP, Van Scott MR, Nakamura RM, Myrvik QN. Th1 adjuvant N-acetyl-d-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Infect. Immun. 69(10), 6123-6130 (2001). (Pubitemid 32885173)
-
(2001)
Infection and Immunity
, vol.69
, Issue.10
, pp. 6123-6130
-
-
Shibata, Y.1
Honda, I.2
Justice, J.P.3
Van Scott, M.R.4
Nakamura, R.M.5
Myrvik, Q.N.6
-
77
-
-
0034142181
-
Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse
-
Shibata Y, Foster LA, Bradfield JF, Myrvik QN. Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J. Immunol. 164(3), 1314-1321 (2000). (Pubitemid 30067244)
-
(2000)
Journal of Immunology
, vol.164
, Issue.3
, pp. 1314-1321
-
-
Shibata, Y.1
Foster, L.A.2
Bradfield, J.F.3
Myrvik, Q.N.4
-
78
-
-
70349201241
-
Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to mycobacterium tuberculosis HIV-1 and helicobacter pylori
-
Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10(10), 1081-1088 (2009).
-
(2009)
Nat. Immunol.
, vol.10
, Issue.10
, pp. 1081-1088
-
-
Gringhuis, S.I.1
Den Dunnen, J.2
Litjens, M.3
Van Der Vlist, M.4
Geijtenbeek, T.B.5
-
79
-
-
34548829647
-
Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan
-
DOI 10.1074/jbc.M702690200
-
Doz E, Rose S, Nigou J et al. Acylation determines the Toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1- independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 282(36), 26014-26025 (2007). (Pubitemid 47443801)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.36
, pp. 26014-26025
-
-
Doz, E.1
Rose, S.2
Nigou, J.3
Gilleron, M.4
Puzo, G.5
Erard, F.6
Ryffel, B.7
Quesniaux, V.F.J.8
-
80
-
-
34548829647
-
Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan
-
DOI 10.1074/jbc.M702690200
-
Doz E, Rose S, Nigou J et al. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1- independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 282(36), 26014-26025 (2007). (Pubitemid 47443801)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.36
, pp. 26014-26025
-
-
Doz, E.1
Rose, S.2
Nigou, J.3
Gilleron, M.4
Puzo, G.5
Erard, F.6
Ryffel, B.7
Quesniaux, V.F.J.8
-
81
-
-
10744224166
-
Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis
-
DOI 10.1016/S0264-410X(03)00274-3
-
Hamasur B, Haile M, Pawlowski A et al. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis. Vaccine 21(25-26), 4081-4093 (2003). (Pubitemid 37338234)
-
(2003)
Vaccine
, vol.21
, Issue.25-26
, pp. 4081-4093
-
-
Hamasur, B.1
Haile, M.2
Pawlowski, A.3
Schroder, U.4
Williams, A.5
Hatch, G.6
Hall, G.7
Marsh, P.8
Kallenius, G.9
Svenson, S.B.10
-
82
-
-
0017030170
-
Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-l-alanyl-d- isoglutamine
-
Yamamura Y, Azuma I, Sugimura K, Yamawaki M, Uemiya M. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-l-alanyl-d-isoglutamine. Gann 67(6), 867-877 (1976).
-
(1976)
Gann.
, vol.67
, Issue.6
, pp. 867-877
-
-
Yamamura, Y.1
Azuma, I.2
Sugimura, K.3
Yamawaki, M.4
Uemiya, M.5
-
83
-
-
12444259829
-
Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner respectively in human monocytic cells in culture
-
Uehara A, Yang S, Fujimoto Y et al. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7(1), 53-61 (2005).
-
(2005)
Cell. Microbiol.
, vol.7
, Issue.1
, pp. 53-61
-
-
Uehara, A.1
Yang, S.2
Fujimoto, Y.3
-
84
-
-
33750557881
-
Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling
-
DOI 10.2174/138161206778743510
-
Takada H, Uehara A. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr. Pharm. Des. 12(32), 4163-4172 (2006). (Pubitemid 44669745)
-
(2006)
Current Pharmaceutical Design
, vol.12
, Issue.32
, pp. 4163-4172
-
-
Takada, H.1
Uehara, A.2
-
85
-
-
0019440936
-
Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D- isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs
-
Azuma I, Okumura H, Saiki I et al. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-l-alanyl-d-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-l-tyrosine in guinea pigs. Infect. Immun. 33(3), 834-839 (1981). (Pubitemid 11051079)
-
(1981)
Infection and Immunity
, vol.33
, Issue.3
, pp. 834-839
-
-
Azuma, I.1
Okumura, H.2
Saiki, I.3
-
86
-
-
0027984259
-
Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants
-
Valensi JP, Carlson JR, Van Nest GA. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 153(9), 4029-4039 (1994).
-
(1994)
J. Immunol.
, vol.153
, Issue.9
, pp. 4029-4039
-
-
Valensi, J.P.1
Carlson, J.R.2
Van Nest, G.A.3
-
87
-
-
0028792511
-
Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59
-
Ott G, Barchfeld GL, Van Nest G. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine 13(16), 1557-1562 (1995).
-
(1995)
Vaccine
, vol.13
, Issue.16
, pp. 1557-1562
-
-
Ott, G.1
Barchfeld, G.L.2
Van Nest, G.3
-
88
-
-
0025901039
-
Phase I trial of ImmTher a new liposome-incorporated lipophilic disaccharide tripeptide
-
Vosika GJ, Cornelius DA, Gilbert CWet al. Phase I trial of ImmTher, a new liposome-incorporated lipophilic disaccharide tripeptide. J. Immunother. 10(4), 256-266 (1991).
-
(1991)
J. Immunother.
, vol.10
, Issue.4
, pp. 256-266
-
-
Vosika, G.J.1
Cornelius, D.A.2
Gilbert, C.W.3
-
89
-
-
0025395754
-
Immunologic and toxicologic study of disaccharide tripeptide glycerol dipalmitoyl: A new lipophilic immunomodulator
-
Vosika GJ, Cornelius DA, Bennek JA, Sadlik JR, Gilbert CW. Immunologic and toxicologic study of disaccharide tripeptide glycerol dipalmitoyl: a new lipophilic immunomodulator. Mol. Biother. 2(1), 50-56 (1990).
-
(1990)
Mol. Biother.
, vol.2
, Issue.1
, pp. 50-56
-
-
Vosika, G.J.1
Cornelius, D.A.2
Bennek, J.A.3
Sadlik, J.R.4
Gilbert, C.W.5
-
90
-
-
7044260110
-
Muramyl peptides as immunopharmacological response modifiers
-
Torrence PF Ed.Academic Press Inc. Orlando FL USA
-
Audibert F, Leclerc C, Chedid L. Muramyl peptides as immunopharmacological response modifiers. In:Biological Response Modifiers. Torrence PF (Ed.).Academic Press, Inc., Orlando, FL, USA, 307-337 (1985).
-
(1985)
Biological Response Modifiers
, pp. 307-337
-
-
Audibert, F.1
Leclerc, C.2
Chedid, L.3
-
91
-
-
0001862656
-
Effectivity of alternative adjuvants in comparison to freunds complete adjuvant
-
Schwarzkopf C, Thiele B. Effectivity of alternative adjuvants in comparison to freund's complete adjuvant. ALTEX 13(5), 22-25 (1996).
-
(1996)
ALTEX
, vol.13
, Issue.5
, pp. 22-25
-
-
Schwarzkopf, C.1
Thiele, B.2
-
92
-
-
0029129657
-
Activation of protein kinase C by mycobacterial cord factor trehalose 6-monomycolate resulting in tumor necrosis factor-a release in mouse lung tissues
-
Sueoka E, Nishiwaki S, Okabe S et al. Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-a release in mouse lung tissues. Jpn J. Cancer Res. 86(8), 749-755 (1995).
-
(1995)
Jpn J. Cancer Res.
, vol.86
, Issue.8
, pp. 749-755
-
-
Sueoka, E.1
Nishiwaki, S.2
Okabe, S.3
-
93
-
-
0021033692
-
Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection
-
DOI 10.1016/0192-0561(83)90015-2
-
Masihi KN, Brehmer W, Lange W, Ribi E. Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection. Int. J. Immunopharmacol. 5(5), 403-410 (1983). (Pubitemid 14239809)
-
(1983)
International Journal of Immunopharmacology
, vol.5
, Issue.5
, pp. 403-410
-
-
Masihi, K.N.1
Brehmer, W.2
Lange, W.3
Ribi, E.4
-
94
-
-
34247645972
-
Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice
-
DOI 10.1016/j.micpath.2007.02.006, PII S088240100700023X
-
Fujita Y, Okamoto Y, Uenishi Y, Sunagawa M, Uchiyama T, Yano I. Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb. Pathog. 43(1), 10-21 (2007). (Pubitemid 46678643)
-
(2007)
Microbial Pathogenesis
, vol.43
, Issue.1
, pp. 10-21
-
-
Fujita, Y.1
Okamoto, Y.2
Uenishi, Y.3
Sunagawa, M.4
Uchiyama, T.5
Yano, I.6
-
95
-
-
0032387991
-
Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine
-
DOI 10.1016/S0264-410X(98)00084-X, PII S0264410X9800084X
-
Koike Y, Yoo YC, Mitobe M et al. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine. Vaccine 16(20), 1982-1989 (1998). (Pubitemid 28473946)
-
(1998)
Vaccine
, vol.16
, Issue.20
, pp. 1982-1989
-
-
Koike, Y.1
Yoo, Y.C.2
Mitobe, M.3
Oka, T.4
Okuma, K.5
Tono-Oka, S.6
Azuma, I.7
-
96
-
-
0016612654
-
Biologically active components from mycobacterial cell walls IV protection of mice against aerosol infection with virulent mycobacterium tuberculosis
-
Ribi E, Meyer TJ, Azuma I, Parker R, Brehmer W. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent Mycobacterium tuberculosis. Cell. Immunol. 16(1), 1-10 (1975).
-
(1975)
Cell. Immunol.
, vol.16
, Issue.1
, pp. 1-10
-
-
Ribi, E.1
Meyer, T.J.2
Azuma, I.3
Parker, R.4
Brehmer, W.5
-
98
-
-
0022544882
-
Immunobiological activities of nontoxic lipid A: Enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects
-
DOI 10.1016/0192-0561(86)90116-5
-
Masihi KN, Lange W, Brehmer W, Ribi E. Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int. J. Immunopharmacol. 8(3), 339-345 (1986). (Pubitemid 16063773)
-
(1986)
International Journal of Immunopharmacology
, vol.8
, Issue.3
, pp. 339-345
-
-
Masihi, K.N.1
Lange, W.2
Brehmer, W.3
Ribi, E.4
-
99
-
-
70450253086
-
Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A
-
Cekic C, Casella CR, Eaves CA, Matsuzawa A, Ichijo H, Mitchell TC. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J. Biol. Chem. 284(46), 31982-31991 (2009).
-
(2009)
J. Biol. Chem.
, vol.284
, Issue.46
, pp. 31982-31991
-
-
Cekic, C.1
Casella, C.R.2
Eaves, C.A.3
Matsuzawa, A.4
Ichijo, H.5
Mitchell, T.C.6
-
100
-
-
49749105995
-
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
-
Schiller JT, Castellsague X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 26(Suppl. 10), K53-K61 (2008).
-
(2008)
Vaccine
, vol.26
, Issue.10
-
-
Schiller, J.T.1
Castellsague, X.2
Villa, L.L.3
Hildesheim, A.4
-
101
-
-
30944443060
-
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients
-
DOI 10.1111/j.1523-1755.2005.00689.x, PII 4494876
-
Tong NK, Beran J, Kee SA et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int. 68(5), 2298-2303 (2005). (Pubitemid 43117807)
-
(2005)
Kidney International
, vol.68
, Issue.5
, pp. 2298-2303
-
-
Tong, N.K.C.1
Beran, J.2
Kee, S.A.3
Miguel, J.L.4
Sanchez, C.5
Bayas, J.M.6
Vilella, A.7
De Juanes, J.R.8
Arrazola, P.9
Calbo-Torrecillas, F.10
De Novales, E.L.11
Hamtiaux, V.12
Lievens, M.13
Stoffel, M.14
-
102
-
-
33846826420
-
Bioactive saponins with cancer related and immunomodulatory activity: Recent developments
-
Atta ur R (Ed.).Elsevier Amsterdam The Netherlands
-
Lacaille-Dubois MA. Bioactive saponins with cancer related and immunomodulatory activity: recent developments. In:Studies in Natural Products Chemistry. Atta ur R (Ed.).Elsevier, Amsterdam, The Netherlands, 209-246 (2005).
-
(2005)
Studies in Natural Products Chemistry
, pp. 209-246
-
-
Lacaille-Dubois, M.A.1
-
103
-
-
0034995733
-
Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages
-
DOI 10.1046/j.1365-2567.2001.01224.x
-
Dai JH, Iwatani Y, Ishida T et al. Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology 103(2), 235-243 (2001). (Pubitemid 32521353)
-
(2001)
Immunology
, vol.103
, Issue.2
, pp. 235-243
-
-
Dai, J.H.1
Iwatani, Y.2
Ishida, T.3
Terunuma, H.4
Kasai, H.5
Iwakula, Y.6
Fujiwara, H.7
Ito, M.8
-
104
-
-
0041337005
-
Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system
-
DOI 10.1078/094471103322331421
-
Raphael TJ, Kuttan G. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine 10(6-7), 483-489 (2003). (Pubitemid 37092670)
-
(2003)
Phytomedicine
, vol.10
, Issue.6-7
, pp. 483-489
-
-
Raphael, T.J.1
Kuttan, G.2
-
105
-
-
0029176755
-
Structural and immunological characterization of the vaccine adjuvant QS-21
-
Kensil CR, Wu JY, Soltysik S. Structural and immunological characterization of the vaccine adjuvant QS-21. Pharm. Biotechnol. 6, 525-541 (1995).
-
(1995)
Pharm. Biotechnol.
, vol.6
, pp. 525-541
-
-
Kensil, C.R.1
Wu, J.Y.2
Soltysik, S.3
-
106
-
-
0030446572
-
Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria
-
Kensil CR, Soltysik S, Wheeler DA, Wu JY. Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria. Adv. Exp. Med. Biol. 404, 165-172 (1996). (Pubitemid 26424086)
-
(1996)
Advances in Experimental Medicine and Biology
, vol.404
, pp. 165-172
-
-
Kensil, C.R.1
Soltysik, S.2
Wheeler, D.A.3
Wu, J.-Y.4
-
107
-
-
15044347193
-
+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: Quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites
-
DOI 10.1016/j.vaccine.2004.10.044
-
+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. Vaccine 23(21), 2801-2812 (2005). (Pubitemid 40381274)
-
(2005)
Vaccine
, vol.23
, Issue.21
, pp. 2801-2812
-
-
Meraldi, V.1
Romero, J.F.2
Kensil, C.3
Corradin, G.4
-
108
-
-
33749561154
-
Saponins from Quillaja saponaria Molina: Isolation, characterization and ability to form Immuno Stimulatory Complexes (ISCOMs)
-
DOI 10.2174/156720106778559092
-
Pham HL, Ross BP, McGeary RP, Shaw PN, Hewavitharana AK, Davies NM. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).Curr. Drug Deliv. 3(4), 389-397 (2006). (Pubitemid 44534051)
-
(2006)
Current Drug Delivery
, vol.3
, Issue.4
, pp. 389-397
-
-
Pham, H.L.1
Ross, B.P.2
McGeary, R.P.3
Shaw, P.N.4
Hewavitharana, A.K.5
Davies, N.M.6
-
109
-
-
61349084783
-
Advances in saponin-based adjuvants
-
Sun HX, Xie Y, Ye YP. Advances in saponin-based adjuvants. Vaccine 27(12), 1787-1796 (2009).
-
(2009)
Vaccine
, vol.27
, Issue.12
, pp. 1787-1796
-
-
Sun, H.X.1
Xie, Y.2
Ye, Y.P.3
-
110
-
-
0034662482
-
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity
-
PII S0264410X00001183
-
Marciani DJ, Press JB, Reynolds RC et al. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity. Vaccine 18(27), 3141-3151 (2000). (Pubitemid 30345696)
-
(2000)
Vaccine
, vol.18
, Issue.27
, pp. 3141-3151
-
-
Marciani, D.J.1
Press, J.B.2
Reynolds, R.C.3
Pathak, A.K.4
Pathak, V.5
Gundy, L.E.6
Farmer, J.T.7
Koratich, M.S.8
May, R.D.9
-
111
-
-
0141882443
-
Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100
-
DOI 10.1016/S0264-410X(03)00298-6
-
Marciani DJ, Reynolds RC, Pathak AK, Finley-Woodman K, May RD. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100. Vaccine 21(25-26), 3961-3971 (2003). (Pubitemid 37338224)
-
(2003)
Vaccine
, vol.21
, Issue.25-26
, pp. 3961-3971
-
-
Marciani, D.J.1
Reynolds, R.C.2
Pathak, A.K.3
Finley-Woodman, K.4
May, R.D.5
-
112
-
-
32544434934
-
Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2
-
DOI 10.1016/j.vaccine.2005.10.017, PII S0264410X05010522
-
Quenelle DC, Collins DJ, Marciani DJ, Kern ER. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. Vaccine 24(10), 1515-1522 (2006). (Pubitemid 43238225)
-
(2006)
Vaccine
, vol.24
, Issue.10
, pp. 1515-1522
-
-
Quenelle, D.C.1
Collins, D.J.2
Marciani, D.J.3
Kern, E.R.4
-
113
-
-
53249115473
-
Effect of an immune enhancer GPI-0100 on vaccination with live attenuated herpes simplex virus HSV type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs
-
Quenelle DC, Collins DJ, Rice TL, Prichard MN, Marciani DJ, Kern ER. Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs. Antiviral Res. 80(2), 223-224 (2008).
-
(2008)
Antiviral Res.
, vol.80
, Issue.2
, pp. 223-224
-
-
Quenelle, D.C.1
Collins, D.J.2
Rice, T.L.3
Prichard, M.N.4
Marciani, D.J.5
Kern, E.R.6
-
114
-
-
0037108769
-
On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines
-
DOI 10.1073/pnas.202427599
-
Ragupathi G, Coltart DM, Williams LJ et al. On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines. Proc. Natl Acad. Sci. USA 99(21), 13699-13704 (2002). (Pubitemid 35215444)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.21
, pp. 13699-13704
-
-
Ragupathi, G.1
Coltart, D.M.2
Williams, L.J.3
Koide, F.4
Kagan, E.5
Allen, J.6
Harris, C.7
Glunz, P.W.8
Livingston, P.O.9
Danishefsky, S.J.10
-
115
-
-
68749105932
-
Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein C4BP
-
Rawal N, Rajagopalan R, Salvi VP. Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).Mol. Immunol. 46(15), 2902-2910 (2009).
-
(2009)
Mol. Immunol.
, vol.46
, Issue.15
, pp. 2902-2910
-
-
Rawal, N.1
Rajagopalan, R.2
Salvi, V.P.3
-
116
-
-
0018611170
-
Purification of a mannan from Candida albicans which activates serum complement
-
Ray TL, Hanson A, Ray LF, Wuepper KD. Purification of a mannan from Candida albicans which activates serum complement. J. Invest. Dermatol. 73(4), 269-274 (1979). (Pubitemid 10161226)
-
(1979)
Journal of Investigative Dermatology
, vol.73
, Issue.4
, pp. 269-274
-
-
Ray, T.L.1
Hanson, A.2
Ray, L.F.3
Wuepper, K.D.4
-
117
-
-
0023191243
-
Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides - Studies on active components and structural requirements
-
Kawasaki A, Takada H, Kotani S et al. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides-studies on active components and structural requirements. Microbiol. Immunol. 31(6), 551-569 (1987). (Pubitemid 17117231)
-
(1987)
Microbiology and Immunology
, vol.31
, Issue.6
, pp. 551-569
-
-
Kawasaki, A.1
Takada, H.2
Kotani, S.3
-
118
-
-
3042606427
-
Cell signals transduced by complement
-
DOI 10.1016/j.molimm.2004.04.007, PII S0161589004001233
-
Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z. Cell signals transduced by complement. Mol. Immunol. 41(6-7), 583-597 (2004). (Pubitemid 38824616)
-
(2004)
Molecular Immunology
, vol.41
, Issue.6-7
, pp. 583-597
-
-
Bohana-Kashtan, O.1
Ziporen, L.2
Donin, N.3
Kraus, S.4
Fishelson, Z.5
-
119
-
-
0025955352
-
Modification of lymphocyte migration by mannans and phosphomannans different carbohydrate structures control entry of lymphocytes into spleen and lymph nodes
-
Weston SA, Parish CR. Modification of lymphocyte migration by mannans and phosphomannans. Different carbohydrate structures control entry of lymphocytes into spleen and lymph nodes. J. Immunol. 146(12), 4180-4186 (1991).
-
(1991)
J. Immunol.
, vol.146
, Issue.12
, pp. 4180-4186
-
-
Weston, S.A.1
Parish, C.R.2
-
120
-
-
0036630093
-
Leishmania major activates IL-1α expression in macrophages through a MyD88-dependent pathway
-
DOI 10.1016/S1286-4579(02)01596-4, PII S1286457902015964
-
Hawn TR, Ozinsky A, Underhill DM, Buckner FS, Akira S, Aderem A. Leishmania major activates IL-1 a expression in macrophages through a MyD88-dependent pathway. Microbes Infect. 4(8), 763-771 (2002). (Pubitemid 35247439)
-
(2002)
Microbes and Infection
, vol.4
, Issue.8
, pp. 763-771
-
-
Hawn, T.R.1
Ozinsky, A.2
Underhill, D.M.3
Buckner, F.S.4
Akira, S.5
Aderem, A.6
-
121
-
-
0037150482
-
QS-21 structure/function studies: Effect of acylation on adjuvant activity
-
DOI 10.1016/S0264-410X(02)00209-8, PII S0264410X02002098
-
Liu G, Anderson C, Scaltreto H, Barbon J, Kensil CR. QS-21 structure/function studies: effect of acylation on adjuvant activity. Vaccine 20(21-22), 2808-2815 (2002). (Pubitemid 34597141)
-
(2002)
Vaccine
, vol.20
, Issue.21-22
, pp. 2808-2815
-
-
Liu, G.1
Anderson, C.2
Scaltreto, H.3
Barbon, J.4
Kensil, C.R.5
-
122
-
-
52049115713
-
Synthesis of QS-21-xylose: Establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine
-
Deng K, Adams MM, Damani P, Livingston PO, Ragupathi G, Gin DY. Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine. Angew. Chem. Int. Ed. Engl. 47(34), 6395-6398 (2008).
-
(2008)
Angew. Chem. Int. Ed. Engl.
, vol.47
, Issue.34
, pp. 6395-6398
-
-
Deng, K.1
Adams, M.M.2
Damani, P.3
Livingston, P.O.4
Ragupathi, G.5
Gin, D.Y.6
-
123
-
-
20244369887
-
Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge
-
DOI 10.1128/IAI.73.5.3044-3052.2005
-
Cluff CW, Baldridge JR, Stover AG et al. Synthetic Toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. Infect. Immun. 73(5), 3044-3052 (2005). (Pubitemid 40570374)
-
(2005)
Infection and Immunity
, vol.73
, Issue.5
, pp. 3044-3052
-
-
Cluff, C.W.1
Baldridge, J.R.2
Stover, A.G.3
Evans, J.T.4
Johnson, D.A.5
Lacy, M.J.6
Clawson, V.G.7
Yorgensen, V.M.8
Johnson, C.L.9
Livesay, M.T.10
Hershberg, R.M.11
Persing, D.H.12
-
124
-
-
2442499153
-
Structure-activity relationship of synthetic Toll-like receptor 4 agonists
-
DOI 10.1074/jbc.M310760200
-
Stover AG, Da Silva Correia J, Evans JT et al. Structure-activity relationship of synthetic Toll-like receptor 4 agonists. J. Biol. Chem. 279(6), 4440-4449 (2004). (Pubitemid 38199033)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.6
, pp. 4440-4449
-
-
Stover, A.G.1
Da Silva Correia, J.2
Evans, J.T.3
Cluff, C.W.4
Elliott, M.W.5
Jeffery, E.W.6
Johnson, D.A.7
Lacy, M.J.8
Baldridge, J.R.9
Probst, P.10
Ulevitch, R.J.11
Persing, D.H.12
Hershberg, R.M.13
|